The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of orally administered 1-Pamitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol (PLAG) for the treatment of chemotherapy-induced neutropenia (CIN) in pancreatic cancer patients undergoing gemcitabine-based chemotherapy: A pilot case-control study.
 
Myung-Hwan Kim
No Relationships to Disclose
 
Tae Jun Song
No Relationships to Disclose
 
Dongwook Oh
No Relationships to Disclose
 
Seong Joon Park
No Relationships to Disclose
 
Jae Wha Kim
No Relationships to Disclose
 
Sun Young Yoon
Employment - Enzychem Lifesciences
 
Hye-Kyung Kim
Employment - Enzychem Lifesciences
Leadership - Enzychem Lifesciences
Stock and Other Ownership Interests - Enzychem Lifesciences
Travel, Accommodations, Expenses - Enzychem Lifesciences
 
Ki Young Sohn
Employment - Enzychem Lifesciences
Leadership - Enzychem Lifesciences
Stock and Other Ownership Interests - Enzychem Lifesciences
Travel, Accommodations, Expenses - Enzychem Lifesciences
 
Yong-Hae Han
Employment - Enzychem Lifesciences
Leadership - Enzychem Lifesciences
Stock and Other Ownership Interests - Enzychem Lifesciences
Travel, Accommodations, Expenses - Enzychem Lifesciences
 
Saeho Chong
Employment - Enzychem Lifesciences
Leadership - Enzychem Lifesciences
Stock and Other Ownership Interests - Enzychem Lifesciences
Travel, Accommodations, Expenses - Enzychem Lifesciences